相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Lead-Time Trajectory of CA19-9 as an Anchor Marker for Pancreatic Cancer Early Detection
Johannes F. Fahrmann et al.
GASTROENTEROLOGY (2021)
IGFBP2 promotes tumor progression by inducing alternative polarization of macrophages in pancreatic ductal adenocarcinoma through the STAT3 pathway
Longhao Sun et al.
CANCER LETTERS (2021)
The Cellular Origins of Cancer-Associated Fibroblasts and Their Opposing Contributions to Pancreatic Cancer Growth
Paul Manoukian et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Preoperative serum carbohydrate antigen 19-9 levels predict early recurrence after the resection of early-stage pancreatic ductal adenocarcinoma
Sarang Hong et al.
WORLD JOURNAL OF GASTROINTESTINAL SURGERY (2021)
Serum insulin-like growth factor binding protein 2 levels as biomarker for pancreatic ductal adenocarcinoma-associated malnutrition and muscle wasting
Jie Dong et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2021)
Stroma Involvement in Pancreatic Ductal Adenocarcinoma: An Overview Focusing on Extracellular Matrix Proteins
Sophie Liot et al.
FRONTIERS IN IMMUNOLOGY (2021)
Role of the IGF-1 Axis in Overcoming Resistance in Breast Cancer
Anna Ianza et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Serum Biomarker Panel for Diagnosis and Prognosis of Pancreatic Ductal Adenocarcinomas
Shreya Mehta et al.
FRONTIERS IN ONCOLOGY (2021)
Insulin-like growth factor 1 and insulin-like growth factor binding protein 2 serum levels as potential biomarkers in differential diagnosis between chronic pancreatitis and pancreatic adenocarcinoma in reference to pancreatic diabetes
Barbara Wlodarczyk et al.
GASTROENTEROLOGY REVIEW-PRZEGLAD GASTROENTEROLOGICZNY (2021)
Elevated CEA and CA19-9 serum levels independently predict advanced pancreatic cancer at diagnosis
Labrinus van Manen et al.
BIOMARKERS (2020)
The effect of resistance training on serum insulin-like growth factor 1(IGF-1): A systematic review and meta-analysis
Qiang Jiang et al.
COMPLEMENTARY THERAPIES IN MEDICINE (2020)
Serum Levels of Insulin-like Growth Factor 1 and Insulin-like Growth Factor-binding Protein 2 as a Novel Biomarker in the Detection of Pancreatic Adenocarcinoma
Barbara Wlodarczyk et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2020)
CA19-9 for detecting recurrence of pancreatic cancer
Azadeh Azizian et al.
SCIENTIFIC REPORTS (2020)
Carbohydrate antigen 19-9 elevation without evidence of malignant or pancreatobiliary diseases
Sunyoung Kim et al.
SCIENTIFIC REPORTS (2020)
Role of Tumor and Stroma-Derived IGF/IGFBPs in Pancreatic Cancer
Divya Thomas et al.
CANCERS (2020)
IGFBP-3/IGFBP-3 Receptor System as an Anti-Tumor and Anti-Metastatic Signaling in Cancer
Qing Cai et al.
CELLS (2020)
Mass-forming pancreatitis versus pancreatic ductal adenocarcinoma: CT and MR imaging for differentiation
Wolfgang Schima et al.
CANCER IMAGING (2020)
The Insulin-Like Growth Factor 2 mRNA Binding Protein IMP2/IGF2BP2 is Overexpressed and Correlates with Poor Survival in Pancreatic Cancer
Charlotte Dahlem et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Chronic Pancreatitis or Pancreatic Tumor? A Problem-solving Approach
Kristy Marie Wolske et al.
RADIOGRAPHICS (2019)
Diagnosis and Management of Chronic Pancreatitis A Review
Vikesh K. Singh et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
IGF1: the Jekyll and Hyde of the aging brain
Sriram Gubbi et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2018)
Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries
Claudia Allemani et al.
LANCET (2018)
Insulin/IGF-driven cancer cell-stroma crosstalk as a novel therapeutic target in pancreatic cancer
Ayse Ceren Mutgan et al.
MOLECULAR CANCER (2018)
Radiotherapy-Activated Cancer-Associated Fibroblasts Promote Tumor Progression through Paracrine IGF1R Activation
Joke Tommelein et al.
CANCER RESEARCH (2018)
Evaluation of insulin-like growth factor (IGF-1) and retinol binding protein (RBP-4) levels in patients with newly diagnosed pancreatic adenocarcinoma (PDAC)
Barbara Wlodarczyk et al.
PANCREATOLOGY (2017)
Serum Insulin-Like Growth Factor Axis and the Risk of Pancreatic Cancer: Systematic Review and Meta-Analysis
Yuanfeng Gong et al.
NUTRIENTS (2017)
Comparing the diagnostic accuracy of five common tumour biomarkers and CA19-9 for pancreatic cancer: a protocol for a network meta-analysis of diagnostic test accuracy
Long Ge et al.
BMJ OPEN (2017)
IGFBP2 Activates the NF-κB Pathway to Drive Epithelial-Mesenchymal Transition and Invasive Character in Pancreatic Ductal Adenocarcinoma
Song Gao et al.
CANCER RESEARCH (2016)
Oncogenic KRAS Regulates Tumor Cell Signaling via Stromal Reciprocation
Christopher J. Tape et al.
CELL (2016)
Guidelines for Growth Hormone and Insulin-Like Growth Factor-I Treatment in Children and Adolescents: Growth Hormone Deficiency, Idiopathic Short Stature, and Primary Insulin-Like Growth Factor-I Deficiency
Adda Grimberg et al.
HORMONE RESEARCH IN PAEDIATRICS (2016)
Pancreatic Fibroblasts Stimulate the Motility of Pancreatic Cancer Cells through IGF1/IGF1R Signaling under Hypoxia
Toshiki Hirakawa et al.
PLOS ONE (2016)
Activated pancreatic stellate cells can impair pancreatic islet function in mice
Guangxiang Zang et al.
UPSALA JOURNAL OF MEDICAL SCIENCES (2015)
Stromal Elements Act to Restrain, Rather Than Support, Pancreatic Ductal Adenocarcinoma
Andrew D. Rhim et al.
CANCER CELL (2014)
Serum IGFBP2 and MSLN as diagnostic and prognostic biomarkers for pancreatic cancer
Zachary W. Kendrick et al.
HPB (2014)
Pancreatic stellate cells reduce insulin expression and induce apoptosis in pancreatic β-cells
Kazuhiro Kikuta et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
Study of an elevated carbohydrate antigen 19-9 concentration in a large health check-up cohort in China
Yuling Tong et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2013)
Signalling by insulin and IGF receptors: supporting acts and new players
Kenneth Siddle
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2011)
Serum CA 19-9 as a Biomarker for Pancreatic Cancer-A Comprehensive Review
Umashankar K. Ballehaninna et al.
INDIAN JOURNAL OF SURGICAL ONCOLOGY (2011)
Nerve Growth Factor and Artemin Are Paracrine Mediators of Pancreatic Neuropathy in Pancreatic Adenocarcinoma
Gueralp O. Ceyhan et al.
ANNALS OF SURGERY (2010)
How do we interpret an elevated carbohydrate antigen 19-9 level in asymptomatic subjects?
B. J. Kim et al.
DIGESTIVE AND LIVER DISEASE (2009)
Persistent elevation of serum CA 19-9 with no evidence of malignant disease
M. Ventrucci et al.
DIGESTIVE AND LIVER DISEASE (2009)
Insulin and insulin-like growth factor signalling in neoplasia
Michael Pollak
NATURE REVIEWS CANCER (2008)
Pancreatic cancer-associated stroma production
Murray Korc
AMERICAN JOURNAL OF SURGERY (2007)
Stromal biology of pancreatic cancer
Gerald C. Chu et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2007)
The pancreatic stellate cell: a star on the rise in pancreatic diseases
M. Bishr Omary et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Systematic review of carbohydrate antigen (CA 19-9) as a biochemical marker in the diagnosis of pancreatic cancer
K. S. Goonetilleke et al.
EJSO (2007)
Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis
AG Renehan et al.
LANCET (2004)
Clinical usefulness of carbohydrate antigen 19-9 as a screening test for pancreatic cancer in an asymptomatic population
JE Kim et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2004)
Cellular actions of the insulin-like growth factor binding proteins
SM Firth et al.
ENDOCRINE REVIEWS (2002)
Elevated tumour marker CA19-9: clinical interpretation and influence of obstructive jaundice
DV Mann et al.
EUROPEAN JOURNAL OF SURGICAL ONCOLOGY (2000)
分享论文
